SRPT
Sarepta Therapeutics Inc
Price:  
123.88 
USD
Volume:  
851,351.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRPT Relative Valuation

-196.9%
Upside

As of 2024-03-05, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is (120.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 123.88 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -196.9%.

The range of the Relative Valuation is (109.88) - (143.91) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.2x - 26.1x 22.3x
Forward P/E multiples 17.8x - 25.1x 19.6x
Fair Price (109.88) - (143.91) (120.02)
Upside -188.7% - -216.2% -196.9%
123.88 USD
Stock Price
(120.02) USD
Fair Price

SRPT Relative Valuation - Historical P/E Data

Date P/E
2024-03-05 -21.16
2024-03-04 -21.62
2024-03-01 -22.46
2024-02-29 -22.33
2024-02-28 -24.00
2024-02-27 -24.70
2024-02-26 -24.03
2024-02-23 -23.83
2024-02-22 -23.53
2024-02-21 -23.09
2024-02-20 -23.76
2024-02-16 -23.50
2024-02-15 -21.80
2024-02-14 -21.70
2024-02-13 -21.68
2024-02-12 -22.22
2024-02-09 -22.15
2024-02-08 -22.23
2024-02-07 -22.00
2024-02-06 -22.07
2024-02-05 -21.91
2024-02-02 -21.17
2024-02-01 -21.44
2024-01-31 -20.77
2024-01-30 -20.79
2024-01-29 -21.03
2024-01-26 -20.72
2024-01-25 -20.95
2024-01-24 -20.98
2024-01-23 -21.14
2024-01-22 -21.13
2024-01-19 -20.19
2024-01-18 -20.39
2024-01-17 -20.43
2024-01-16 -20.14
2024-01-12 -20.39
2024-01-11 -20.26
2024-01-10 -20.80
2024-01-09 -20.91
2024-01-08 -17.91
2024-01-05 -16.99
2024-01-04 -16.46
2024-01-03 -16.36
2024-01-02 -16.79
2023-12-29 -16.83
2023-12-28 -17.07
2023-12-27 -16.90
2023-12-26 -16.81
2023-12-22 -16.50
2023-12-21 -15.84